Michael P. Woodward

Array ( [id] => 3846939 [patent_doc_number] => 05766845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Immunoreactive polypeptide compositions' [patent_app_type] => 1 [patent_app_number] => 8/440210 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 18130 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766845.pdf [firstpage_image] =>[orig_patent_app_number] => 440210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723165 [patent_doc_number] => 05670153 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Immunoreactive polypeptide compositions' [patent_app_type] => 1 [patent_app_number] => 8/440542 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 18128 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670153.pdf [firstpage_image] =>[orig_patent_app_number] => 440542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786976 [patent_doc_number] => 05780036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus' [patent_app_type] => 1 [patent_app_number] => 8/416950 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10862 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780036.pdf [firstpage_image] =>[orig_patent_app_number] => 416950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756767 [patent_doc_number] => 05843636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Hepatitis C virus epitopes' [patent_app_type] => 1 [patent_app_number] => 8/407410 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25549 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843636.pdf [firstpage_image] =>[orig_patent_app_number] => 407410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766341 [patent_doc_number] => 05773215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Tumor marker protein for cancer risk assessment' [patent_app_type] => 1 [patent_app_number] => 8/405648 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10848 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773215.pdf [firstpage_image] =>[orig_patent_app_number] => 405648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549278 [patent_doc_number] => 06346375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'NANBV diagnostics and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/403590 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 168 [patent_figures_cnt] => 180 [patent_no_of_words] => 79083 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346375.pdf [firstpage_image] =>[orig_patent_app_number] => 08403590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4145135 [patent_doc_number] => 06031081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Process for reactivating purified membrane proteins by freezing them' [patent_app_type] => 1 [patent_app_number] => 8/397952 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1700 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031081.pdf [firstpage_image] =>[orig_patent_app_number] => 397952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781587 [patent_doc_number] => 05736146 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them' [patent_app_type] => 1 [patent_app_number] => 8/379613 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 49 [patent_no_of_words] => 11668 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736146.pdf [firstpage_image] =>[orig_patent_app_number] => 379613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855217 [patent_doc_number] => 05792463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Hybrid particle immunogens' [patent_app_type] => 1 [patent_app_number] => 8/352989 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11793 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792463.pdf [firstpage_image] =>[orig_patent_app_number] => 352989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647051 [patent_doc_number] => 05639637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Hepatitis B vaccine' [patent_app_type] => 1 [patent_app_number] => 8/339281 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6117 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639637.pdf [firstpage_image] =>[orig_patent_app_number] => 339281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992018 [patent_doc_number] => 05985609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Process for preparing hepatitis C virus envelope glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/334545 [patent_app_country] => US [patent_app_date] => 1994-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 5910 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985609.pdf [firstpage_image] =>[orig_patent_app_number] => 334545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691263 [patent_doc_number] => 05650155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Tocols as adjuvant in vaccine' [patent_app_type] => 1 [patent_app_number] => 8/320202 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3193 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650155.pdf [firstpage_image] =>[orig_patent_app_number] => 320202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942023 [patent_doc_number] => 05981645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Crosslinkable creping adhesives' [patent_app_type] => 1 [patent_app_number] => 8/310377 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3600 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981645.pdf [firstpage_image] =>[orig_patent_app_number] => 310377 [rel_patent_id] =>[rel_patent_doc_number] =>)